Protective effect of propofol and its relation to postoperation recovery in children undergoing cardiac surgery with cardiopulmonary bypass

Pediatric Cardiology

Volumn 32, Issue 7, 2011, Pages 940-946

  Xia, Wen Fang ^a   Liu, Yu ^a,b   Zhou, Qing Shan ^a   Tang, Qi Zhu ^a,b   Zou, Han Dong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Cardiopulmonary bypass; Children; Inflammation; Oxidative stress; Propofol

Indexed keywords

CREATINE KINASE; ENFLURANE; FENTANYL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MIDAZOLAM; MORPHINE; PANCURONIUM; PROPOFOL; SCOPOLAMINE; SUPEROXIDE DISMUTASE; HYPNOTIC SEDATIVE AGENT;

ANESTHETIC RECOVERY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AORTA CLAMPING; ARTICLE; BLOOD SAMPLING; CARDIAC PATIENT; CARDIOPULMONARY BYPASS; CELL INFILTRATION; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; ENZYME BLOOD LEVEL; EXTUBATION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RIGHT ATRIUM; HEART SURGERY; HOSPITALIZED CHILD; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; PEDIATRIC ANESTHESIA; PEDIATRIC SURGERY; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; SCHOOL CHILD; SURGICAL PATIENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONGENITAL HEART MALFORMATION; CONTROLLED CLINICAL TRIAL; CONVALESCENCE; DOSE RESPONSE; FEMALE; FOLLOW UP; HEART MUSCLE; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; METHODOLOGY; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; TREATMENT OUTCOME;

CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; INJECTIONS, INTRAVENOUS; MALE; MYOCARDIUM; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PROPOFOL; RECOVERY OF FUNCTION; TREATMENT OUTCOME;

EID: 84859649692     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-011-0018-5     Document Type: Article

References (23)

1. Altavilla D, Deodato B, Campo GM, Arlotta M, Miano M, Squadrito G et al (2000) IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury. Cardiovasc Res 47:515-528
2. An K, Shu H, Huang W, Huang X, Xu M, Yang L et al (2008) Effects of propofol on pulmonary inflammatory response and dysfunction induced by cardiopulmonary bypass. Anaesthesia 63:1187-1192
3. Cavalca V, Colli S, Veglia F, Eligini S, Zingaro L, Squellerio I et al (2008) Anesthetic propofol enhances plasma gamma-tocopherol levels in patients undergoing cardiac surgery. Anesthesiology 108:988-997
4. Corcoran TB, Engel A, Sakamoto H, O'Callaghan-Enright S, O'Donnell A, Heffron JA et al (2004) The effects of propofol on lipid peroxidation and inflammatory response in elective coronary artery bypass grafting. J Cardiothorac Vasc Anesth 18:592-604
5. Corcoran TB, Engel A, Sakamoto H, O'Shea A, O'Callaghan-Enright S, Shorten GD (2006) The effects of propofol on neutrophil function, lipid peroxidation and inflammatory response during elective coronary artery bypass grafting in patients with impaired ventricular function. Br J Anaesth 97:825-831
6. Evans ZP, Mandavilli BS, Ellett JD, Rodwell D, Fariss MW, Fiorini RN et al (2009) Vitamin E succinate enhances steatotic liver energy status and prevents oxidative damage following ischemia/reperfusion. Transplant Proc 41:4094-4098
7. Fan H, Sun B, Gu Q, Lafond-Walker A, Cao S, Becker LC (2002) Oxygen radicals trigger activation of NF-kappaB and AP-1 and upregulation of ICAM-1 in reperfused canine heart. Am J Physiol Heart Circ Physiol 282:H1778-H1786
8. Ji L, Fu F, Zhang L, Liu W, Cai X, Zhang L et al (2010) Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. Am J Physiol Endocrinol Metab 298:E871-E880
9. Kokita N, Hara A, Abiko Y, Arakawa J, Hashizume H, Namiki A (1998) Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth Analg 86:252-258
10. Kukielka GL, Hawkins HK, Michael L, Manning AM, Youker K, Lane C et al (1993) Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium. J Clin Investig 92:1504-1516
11. Levonen AL, Vähäkangas E, Koponen JK, Ylä-Herttuala S (2008) Antioxidant gene therapy for cardiovascular disease: current status and future perspectives. Circulation 117:2142-2150
12. Murphy GJ, Angelini GD (2004) Side effects of cardiopulmonary bypass: What is the reality? J Card Surg 19:481-488
13. Nelson SK, Bose S, Rizeq M, McCord JM (2005) Oxidative stress in organ preservation: a multifaceted approach to cardioplegia. Biomed Pharmacother 59:149-157
14. Shin IW, Jang IS, Lee SH, Baik JS, Park KE, Sohn JT et al (2010) Propofol has delayed myocardial protective effects after a regional ischemia/reperfusion injury in an in vivo rat heart model. Korean J Anesthesiol 58:378-382
15. Suleiman MS, Zacharowski K, Angelini GD (2008) Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics. Br J Pharmacol 153:21-33
16. Toledo-Pereyra LH, Lopez-Neblina F, Toledo AH (2004) Reactive oxygen species and molecular biology of ischemia/reperfusion. Ann Transplant 9:81-83
17. Wang B, Shravah J, Luo H, Raedschelders K, Chen DD, Ansley DM (2009) Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation. Biochem Biophys Res Commun 389:105-111
18. Xia Z, Godin DV, Chang TK, Ansley DM (2003) Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2t-isoprostane formation. Can J Physiol Pharmacol 81:14-21
19. Xia Z, Huang Z, Ansley DM (2006) Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane. Anesth Analg 103:527-532
20. Xia WF, Liu Y, Zhou QS, Tang QZ, Zou HD (2011) Comparison of the effects of propofol and midazolam on inflammation and oxidase stress in children with congenital heart disease undergoing cardiac surgery. Yonsei Med J 52:326-332
21. Xu JH, Zhao YY, Wang JK, Yuan ZG, Zhang TZ (2010) Effects of mouse recombinant bone morphogenetic protein-7 transfection on cell apoptosis, NF-kappaB, and downstream genes in cultured primary cardiomyocytes after simulated ischemia and reperfusion injury. J Cardiovasc Pharmacol 56:69-77
22. Zhang SH, Wang SY, Yao SL (2004) Antioxidative effect of propofol during cardiopulmonary bypass in adults. Acta Pharmacol Sin 25:334-340
23. Zheng JH, Gao BT, Jiang ZM, Yu XQ, Xu ZW (2010) Evaluation of early macrophage activation and NF-kappaB activity in pulmonary injury caused by deep hypothermia circulatory arrest: an experimental study. Pediatr Cardiol 31:215-221